Brought to you by 
Juvaris gets vaccine technology from Colorado State
02 Jun 2004
Executive Summary
Juvaris BioTherapeutics (cationic lipids complexed with DNA to spur immune response) has licensed the exclusive right to develop therapeutic vaccines using Colorado State University's new technology for linking pattern-recognition receptor ligands to lipids.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Juvaris gets vaccine technology from Colorado State
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice